Aveo Pharmaceuticals Inc AVEO:NASDAQ

Last Price$4.15NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/18/22

Today's Change-0.10(2.35%)
Bid (Size)$2.60 (1)
Ask (Size)$4.17 (33)
Day Low / High$4.03 - 4.24
Volume171.5 K

AVEO Oncology Working With NiKang Therapeutics to Develop Combination Therapy for Kidney Cancer

11:22AM ET 1/05/2022 MT Newswires
AVEO Oncology (AVEO) and NiKang Therapeutics said Wednesday they are working together to develop a potential treatment for advanced clear cell renal cell carcinoma, a type of kidney cancer.

The companies will evaluate NiKang's NKT2152 in combination with AVEO's Fotivda in a phase 2 trial that is expected to begin this year. The trial will assess the combination therapy's safety and efficacy in patients who have not responded or relapsed from previous treatments.

NiKang will sponsor the study, while AVEO will co-fund it, according to a statement.

Price: 4.70, Change: -0.49, Percent Change: -9.54